Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Optoregulated Drug Release from an Engineered Living Hydrogel

14 September 2018, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A living hydrogel has been developed with metabolically and optogenetically engineered E. coli encapsulated within an agarose-based hydrogel matrix to produce and release deoxyviolacein in response to blue light irradiation. Localized, tunable and prolonged drug release have been demonstrated.

Keywords

Hydrogel
E. coli
Deoxyviolacein
Optogenetics
Metabolic Engineering
Controlled Release

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

Sep 14, 2018 Version 1

Metrics

3,619
1,116
1
Views
Downloads

License

CC logo
CC
BY logo
BY
NC logo
NC
ND logo
ND
The content is available under CC BY NC ND 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv.7087010.v1
D O I: 10.26434/chemrxiv.7087010.v1 [opens in a new tab]

Funding

DFG SFB1027

Author’s competing interest statement

The authors declare no conflict of interests

Share